impact of SAH. In the present study, we examined the effects of pretreatment with two endotoxin analogs on the activity of the antioxidant enzyme SOD and on cerebral vasospasm following SAH.
Materials and Methods

Animal Preparation
All experimental protocols were approved by the University of Virginia Animal Research Committee. New Zealand White rabbits weighing 3 to 4 kg each were subjected to experimental SAH by injecting autologous blood, as described in detail later in this section. The animals received intracisternal injections of drug or vehicle (saline) immediately before and 24 hours after induction of SAH and were killed 48 hours after the onset of SAH by perfusion fixation. Forty rabbits were randomly assigned to one of five groups: 1) control (without SAH); 2) SAH only; 3) SAH plus vehicle (saline); 4) SAH plus MPL (5 g/kg); or 5) SAH plus DPL (5 g/kg). The MPL and DPL were dissolved in saline, thoroughly vortexed, and sonicated before administration.
Experimental SAH
Subarachnoid hemorrhage was produced in the following manner. The rabbits were anesthetized by an intramuscular injection of a mixture of 9 mg/kg xylocaine (Rompun) and 55 mg/kg ketamine (Ketaset). The animals were intubated with an endotracheal tube. Three milliliters of arterial blood was taken from the ear artery and injected into the cisterna magna by using a 23-gauge butterfly needle. The animals were positioned in ventral recumbency for at least 15 minutes after injection of the blood to allow ventral clot formation. The rabbits were monitored closely for respiratory distress and ventilated as needed, after which they were extubated and returned to the vivarium when they were fully awake.
Morphometric Studies
Forty-eight hours after SAH occurred, perfusion fixation was performed in the following manner. All animals were reanesthethized, intubated, and ventilated with a small animal ventilator. The animals were paralyzed by an intramuscular injection of pancuronium bromide (0.3 mg/kg). The ear artery was catheterized to monitor arterial blood gas levels. Perfusion fixation was performed using transthoracic cannulation of the left ventricle and perfusion with 300 ml Hank's balanced salt solution (HBSS), pH 7.4, at 37˚C, followed by a 200-ml mixture of 2% paraformaldehyde and 2.5% glutaraldehyde in HBSS, pH 7.4, at 37˚C. All perfusions were performed at a pressure of 120 cm H 2 O. After perfusion fixation, the brains were removed, placed in the same fixative solution, and stored at 4˚C overnight.
Basilar arteries were dissected from the brainstem and cut into segments. The middle third of each basilar artery was dissected and washed several times in 0.1 M phosphate-buffered saline (PBS), pH 7.4. The arteries were fixed in 1% osmium tetroxide in PBS for 1 hour at room temperature and washed again with PBS. Dehydration of vessels was achieved by passing them through a series of graded ethyl alcohol baths followed by immersion in a 1:1 mixture of propylene oxide and epoxy resin overnight. The next day the vessels were flat-embedded in 100% epoxy resin and allowed to polymerize at 60˚C for 48 hours. Cross sections of basilar arteries were cut at a thickness of 0.5 m with an ultramicrotome; then they were mounted on glass slides and stained with 0.5% toluidine blue for morphometric analyses.
Arterial cross sections from each animal were analyzed by an investigator who was blinded to the treatment group to which the artery belonged. The vessels were evaluated qualitatively for the extent of corrugation of the internal elastic lamina. In addition, the vessels were analyzed quantitatively using computer-assisted morphometric analysis. The quantitative analysis involved an automated measurement of the cross-sectional area of each section. The luminal areas of five cross sections from a given artery were averaged to provide a single value for each animal.
Measurement of SOD Activity
Basal SOD Activity. Twenty-four rabbits were divided into three groups and treated with: 1) saline; 2) MPL (5 g/kg); or 3) DPL (5 g/kg). The animals in this series were not subjected to SAH. Twenty-four hours after intracisternal drug administration, these animals were killed.
Superoxide Dismutase Activity After SAH. Another series of 18 animals was subjected to SAH and analyzed for SOD activity. These animals were divided into three groups receiving: 1) saline; 2) MPL (5 g/kg); or 3) DPL (5 g/kg). The induction of SAH and drug treatments were performed in the manner described earlier in the morphometric series. The animals were killed 48 hours after induction of SAH.
Superoxide Dismutase Activity Assay. The animals were anesthetized and perfused transcardially with saline, after which the basilar arteries were removed from the brainstem. The activity of SOD was assayed as described in detail elsewhere. 17, 21 Briefly, the basilar artery was homogenized in 10 vol of 50 mM potassium phosphate buffer (pH 7.8) containing 0.1 mM ethylenediamine tetraacetic acid (EDTA). The samples were incubated at 4°C for 20 minutes and centrifuged at 16,000 G for 15 minutes. The SOD activity was measured by assaying the ability of endogenous SOD to inhibit superoxide radical-dependent cytochrome C reduction. The assay medium contained 20 M cytochrome C (type III from horse heart), 100 M xanthine, and sample supernatant, with a final volume of 1 ml. The reaction was initiated by adding 16.7 l of xanthine oxidase solution (Grade I from buttermilk), which was sufficient to produce 0.02 to 0.03 absorbance U/minute, as measured spectrophotometrically at 550 nm in the absence of sample. The rate of cytochrome C reduction was recorded for each sample using a standard spectrophotometer over 1 minute at a wavelength of 550 nm. One unit of SOD is defined as the amount of SOD in brain homogenate required to inhibit 50% of the rate of cytochrome C reduction. The protein was assayed by using the phenol reagent method and the SOD activity is presented as units per milligram of protein.
Statistical Analysis
All data are presented as the mean Ϯ standard error of the mean (SEM). Differences among groups in arterial area and SOD activity were compared by factorial analysis of variance (ANOVA) with Fisher's protected least significant differences (LSD) test. Probability values that were less than 0.05 were considered significant.
Sources of Supplies and Equipment
The MPL and DPL were purchased from RIBI ImmunoChem Research (Hamilton, MT). The HBSS, cytochrome C, xanthine, xanthine oxidase, and EDTA were obtained from Sigma Chemical Co. (St. Louis, MO). Cross sections of basilar arteries were cut with an Ultracut E ultramicrotome (Reichert, Vienna, Austria). To maintain the animals, we used a ventilator (model 683) available from Harvard Apparatus Co. (South Natick, MA). The vessels were analyzed quantitatively by using Image I software obtained from Universal Imaging Co. (West Chester, PA). The spectrophotometer used in the SOD activity assay (model U2000) was obtained from Hitachi Instruments, Inc. (San Jose, CA).
Results
General Observations
A thick subarachnoid clot was observed over the basal surface of the brainstem in each animal subjected to SAH. Table 1 displays the physiological parameters, measured at the time of perfusion fixation, for the groups of animals in the morphometric studies. There were no significant differences among the groups with respect to blood pH, PCO 2 , or PO 2 . Basilar arteries in animals subjected to SAH were constricted relative to control animals (Fig. 1) . In the SAH-only group, constriction of the basilar arteries was severe, and substantial corrugation of the internal elastic lamina was observed. Constriction and corrugation of the basilar artery were attenuated in animals treated with MPL (Fig. 1) .
Cross-Sectional Area Measurements Effects of Endotoxin Analogs on Vasospasm After SAH.
Experimental SAH constricted the basilar arteries in each group of animals. Average cross-sectional areas of basilar arteries were reduced from control levels by 68% and 62% in the SAH-only group and the SAH plus vehicle group, respectively. The SAH-induced reduction in the size of basilar arteries was attenuated in animals treated with MPL (Fig. 2) . The average cross-sectional area was reduced from control levels by 32% in the group receiving 5 g/kg MPL; this effect achieved statistical significance (p Ͻ 0.01 compared with the SAH plus vehicle group; Fisher's protected LSD test). The average cross-sectional area in the DPL-treated group did not differ significantly from that of the SAH plus vehicle group.
Superoxide Dismutase Activity
Effects of Endotoxin Analogs on Basal SOD Activity. The basal SOD activity of basilar arteries in control animals was 8647.7 Ϯ 3290.3 U/mg protein. Twenty-four hours after intracisternal administration of 5 g/kg MPL, SOD activity was increased to 50,849.4 Ϯ 17,214.5 U/mg protein (p Ͻ 0.05) (Fig. 3 left) . The level of basal SOD activity in the group receiving 5 g/kg DPL was higher than control levels (15,587.1 Ϯ 9238.2); however, this difference did not achieve statistical significance.
Effects of Endotoxin Analogs on SOD Activity After SAH.
The SOD activity was significantly reduced from control levels 48 hours after SAH occurred in all groups. In the SAH plus vehicle group, SOD levels were 52 Ϯ 17.2 U/mg protein (p Ͻ 0.01 compared with basal SOD activity). Treatment with MPL attenuated the reduction of SOD activity after SAH ( Fig. 3 right) ; the SOD activity in the SAH plus MPL group was 262.6 Ϯ 111.3 U/mg protein (p Ͻ 0.05 compared with SAH plus vehicle group). The SOD activity in the SAH plus DPL group (54.4 Ϯ 25.2 U/mg protein) did not differ significantly from that observed in the SAH plus vehicle group.
Discussion
Oxygen free radicals appear to be major contributing factors to the pathogenesis of cerebral vasospasm. Oxyhemoglobin released from lysed erythrocytes in the subarachnoid space may generate superoxide products and produce polyunsaturated fatty acids, which lead to lipid peroxide formation. 14, 31 Oxygen radicals and lipid peroxides, through the peroxidation of membrane phospholipids, can compromise the structure and function of cells in the arterial wall. 2, 14, 29, 30 Administration of exogenous antioxidant enzymes, such as SOD and catalase, have been shown to inhibit oxyhemoglobin-induced contractions of cerebral arteries. 15 Moreover, free radical scavengers exert significant protective effects in both clinical and experimental cerebral vasospasm. 3, 10, 12, 13, 15, 20, 32, 34, 35 Although SOD activity has been shown to be affected in the brain parenchyma after SAH, 8, 9, 18 the role of endogenous antioxidant systems in SAH-induced injury to cerebral arteries has remained poorly understood. The present findings indicate that SAH substantially reduces the endogenous antioxidant activity of SOD. This reduction presumably occurs as a result of increased oxidative challenge in the vessel. Pretreatment of cerebral vessels with a relatively nontoxic derivative of endotoxin, MPL, attenuates the reduction in SOD activity elicited by SAH. In addition, MPL by itself enhances basal SOD activity substantially. The upregulation of basal SOD activity and the attenuation of SAH-induced reductions in SOD by MPL are associated with a significant amelioration of cerebral vasospasm. In contrast, another more toxic endotoxin derivative, DPL, did not significantly alter basal SOD activity or the reduction of SOD activity in response to SAH. The DPL was also ineffective in blocking SAH-induced cerebral vasospasm. These observations are consistent with the concept that an impairment of endogenous antioxidant enzyme activity may contribute to SAH-induced vasospasm. In addition, the results suggest that the upregulation of endogenous SOD activity may provide a protective influence against SAH-induced vascular damage.
Monophosphoryl lipid A is a purified endotoxin product obtained by acid and alkaline hydrolysis of Salmonella minnesota R595 lipopolysaccharide. 24, 25 The MPL is 100 to 10,000 times less toxic than endotoxin but retains many of the immunostimulatory features of its parent toxin. 33 Treatment with MPL has been shown to provide protective effects against endotoxic shock 4, 5 and cardiac ischemia-reperfusion. tolerated and current targets for the development of MPL therapy include: 1) septic shock; 2) ischemic injury associated with coronary artery surgery; and 3) inclusion as an adjuvant for vaccines. 4, 7 The present study suggests that MPL-based therapy could also be of value in the treatment of cerebral vasospasm following SAH. Treatment with MPL immediately before and 24 hours after SAH provides a substantial and significant attenuation of cerebral vasospasm in the rabbit. This type of therapeutic approach could also be of value in human patients who have suffered SAH. Following SAH in humans, there is a delay of a day or more before the onset of angiographic or clinical vasospasm. Based on the present study, it is conceivable that early intervention with MPL could suppress the progression of the vasospastic response within this time frame. An important goal of future studies will be to identify the precise time course over which MPL treatment is effective and to continue evaluating the mechanisms underlying this unique form of cerebral protection.
